Cocrystal Pharma, Inc.
USD0.95
-0.00 (-0.01%)
CEO
James E. Sapirstein
IPO Date
2012-02-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.97
Prev. Close
$0.95
Day Low
$0.95
Day High
$0.97
52W Low
$0.86
52W High
$2.67
Market Cap
$0.01B
Volume
0.01M
| 20,000 |
| $1.00 |
| 9 Feb 2026 | FROST PHILLIP MD ET AL | director, 10 percent owner: | P-Purchase | Acquired | 50,000 | $0.95 |
| 13 Jan 2026 | Kornberg Roger D. | director | A-Award | Acquired | 24,615 | $1.10 |
| 13 Jan 2026 | PFENNIGER RICHARD C JR | director | A-Award | Acquired | 16,410 | $1.10 |
| 13 Jan 2026 | Lee Sam | President and Co-CEO | A-Award | Acquired | 49,229 | $1.10 |
| 13 Jan 2026 | Hassan Fred | director | A-Award | Acquired | 16,410 | $1.10 |
| 13 Jan 2026 | Martin James Joseph | Co-CEO and CFO | A-Award | Acquired | 49,229 | $1.10 |
| 13 Jan 2026 | FROST PHILLIP MD ET AL | director, 10 percent owner: | A-Award | Acquired | 24,615 | $1.10 |
| 13 Jan 2026 | Japour Anthony J | director | A-Award | Acquired | 16,410 | $1.10 |